These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7659531)

  • 1. Random recombination of antibody single chain Fv sequences after fragmentation with DNaseI in the presence of Mn2+.
    Lorimer IA; Pastan I
    Nucleic Acids Res; 1995 Aug; 23(15):3067-8. PubMed ID: 7659531
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of DNA shuffling for high fidelity recombination.
    Zhao H; Arnold FH
    Nucleic Acids Res; 1997 Mar; 25(6):1307-8. PubMed ID: 9092645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human single-chain Fv fragments from a combinatorial library using the loxP-Cre recombination system.
    Biard-Piechaczyk M; Teulon I; Peraldi-Roux S; Del Rio M; Pau B; Embleton J
    Hum Antibodies; 1999; 9(1):67-77. PubMed ID: 10331188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadening the impact of antibody phage display technology. Amplification of immunoglobulin sequences from species other than humans or mice.
    O'Brien PM; Aitken R
    Methods Mol Biol; 2002; 178():73-86. PubMed ID: 11968511
    [No Abstract]   [Full Text] [Related]  

  • 6. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes.
    van Wyngaardt W; Malatji T; Mashau C; Fehrsen J; Jordaan F; Miltiadou D; du Plessis DH
    BMC Biotechnol; 2004 Apr; 4():6. PubMed ID: 15059288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage libraries for generation of anti-botulinum scFv antibodies.
    Amersdorfer P; Marks JD
    Methods Mol Biol; 2000; 145():219-40. PubMed ID: 10820725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene cloning, expression and immunological identification of a single chain antibody fragment 3D3 against dengue type 3 virus].
    Si B; Yang P; Qin E
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):229-32. PubMed ID: 12526322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random multirecombinant polymerase chain reaction.
    Tsuji T; Onimaru M; Kitagawa M; Kojoh K; Tabata N; Yanagawa H
    Methods Enzymol; 2004; 388():61-75. PubMed ID: 15289062
    [No Abstract]   [Full Text] [Related]  

  • 12. Generation of humanized monoclonal antibodies by 'best fit' framework selection and recombinant polymerase chain reaction.
    Lewis AP; Crowe JS
    Year Immunol; 1993; 7():110-8. PubMed ID: 8372500
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a new intrabody directed against the N-terminal region of human p53.
    Cohen PA; Mani JC; Lane DP
    Oncogene; 1998 Nov; 17(19):2445-56. PubMed ID: 9824155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Soluble expression and identification of expressed single chain antibody fragment 3D3 against dengue virus type 3].
    Si B; Yang P; Qin E
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):350-2. PubMed ID: 12526352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Developments Toward Antibody Engineering and Affinity Maturation.
    Rathore AS; Sarker A; Gupta RD
    Protein Pept Lett; 2018; 25(10):886-896. PubMed ID: 30255742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of an active single chain Fv antibody from a protein linker library prepared by enzymatic inverse PCR.
    Stemmer WP; Morris SK; Wilson BS
    Biotechniques; 1993 Feb; 14(2):256-65. PubMed ID: 8431292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring natural effector functions. Antibody engineering beyond humanization.
    Brekke OH; Thommesen JE
    Methods Mol Biol; 2003; 207():383-91. PubMed ID: 12412487
    [No Abstract]   [Full Text] [Related]  

  • 19. Shuffled antibody libraries created by in vivo homologous recombination and yeast surface display.
    Swers JS; Kellogg BA; Wittrup KD
    Nucleic Acids Res; 2004 Feb; 32(3):e36. PubMed ID: 14978223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementarity-determining region (CDR) implantation: a theme of recombination.
    Söderlind E; Ohlin M; Carlsson R
    Immunotechnology; 1999 Mar; 4(3-4):279-85. PubMed ID: 10231097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.